Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

ANNALS OF ONCOLOGY

OXFORD UNIV PRESS

1. Amgen Dompe
2. AROG Bayer
3. Blueprint Medicines
4. Eli Lilly
5. Daiichi Sankyo Pharma
6. Epizyme
7. GlaxoSmithKline
8. Novartis
9. Pfizer
10. PharmaMar
11. Incyte
12. Lilly
13. Bayer
14. Janssen-Cilag
15. Eisai
16. Loxo Oncology
17. Nanobiotix
18. Bristol-Myers Squibb
19. Merck Sharp Dohme
20. Roche
21. Amgen
22. EuroSarc
23. CoBioRes
24. Exelixis
25. Plexxikon
26. Sixth Element Capital
27. Adaptaimmune
28. Amcure
29. AstraZeneca
30. Boehringer Ingelheim
31. Cristal Therapeutics
32. Daichii Sankyo Pharma
33. Genzyme
34. Ipsen
35. Medpace
36. Nektar
37. Philogen
38. Piqur Therapeutics
39. Swedish Orphan Biovitrium
40. Advenchen
41. Epizyme Inc.
42. PharmarMar
43. Novartis Oncology
44. Milestone
45. Menarini